Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    Ustekinumab crohn's phase 3 | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: JNJ-64304500;   Drug: Placebo;   Drug: Ustekinumab
2 Not yet recruiting A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Ustekinumab

Study has passed its completion date and status has not been verified in more than two years.